These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 24632699

  • 61. Arthritis in Kawasaki disease after responding to intravenous immunoglobulin treatment.
    Lee KY, Oh JH, Han JW, Lee JS, Lee BC.
    Eur J Pediatr; 2005 Jul; 164(7):451-2. PubMed ID: 15782294
    [No Abstract] [Full Text] [Related]

  • 62. Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease.
    Wada Y, Kamei A, Fujii Y, Ishikawa K, Chida S.
    J Pediatr; 2006 Mar; 148(3):399-400. PubMed ID: 16615977
    [Abstract] [Full Text] [Related]

  • 63. Kawasaki Shock Syndrome and Covid-19.
    Ashraf S, Abbasi FS, Atiq M.
    J Coll Physicians Surg Pak; 2021 Jul; 31(7):135-137. PubMed ID: 34271815
    [Abstract] [Full Text] [Related]

  • 64. Kawasaki disease: part II. Complications and treatment.
    Bayers S, Shulman ST, Paller AS.
    J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
    [Abstract] [Full Text] [Related]

  • 65. The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
    Ogata S, Bando Y, Kimura S, Ando H, Nakahata Y, Ogihara Y, Kaneko T, Minoura K, Kaida M, Yokota Y, Furukawa S, Ishii M.
    J Cardiol; 2009 Feb; 53(1):15-9. PubMed ID: 19167633
    [Abstract] [Full Text] [Related]

  • 66. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids.
    Wright DA, Newburger JW, Baker A, Sundel RP.
    J Pediatr; 1996 Jan; 128(1):146-9. PubMed ID: 8551407
    [Abstract] [Full Text] [Related]

  • 67. [Kawasaki disease with severe manifestations and macrophage activation syndrome in a pediatric patient].
    Vélez-Tirado N, López G, Mijail Chío I, Gutiérrez Hernández A.
    Arch Argent Pediatr; 2019 Dec 01; 117(6):e676-e678. PubMed ID: 31758909
    [Abstract] [Full Text] [Related]

  • 68. Kawasaki disease presenting with intussusception: a case report.
    Hussain RN, Ruiz G.
    Ital J Pediatr; 2010 Jan 19; 36():7. PubMed ID: 20180974
    [Abstract] [Full Text] [Related]

  • 69. Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.
    Patel A, Holman RC, Callinan LS, Sreenivasan N, Schonberger LB, Fischer TK, Belay ED.
    Acta Paediatr; 2013 Apr 19; 102(4):385-90. PubMed ID: 23278838
    [Abstract] [Full Text] [Related]

  • 70. [Kawasaki syndrome: review of the literature and presentation of 4 clinical cases].
    De Martino MP, Grenci G, Costantino D, Mammì F, Stilo L, Costantino G.
    Pediatr Med Chir; 1994 Apr 19; 16(1):63-7. PubMed ID: 8029092
    [Abstract] [Full Text] [Related]

  • 71. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.
    Khan S, Doré PC, Sewell WA.
    Pediatr Allergy Immunol; 2008 Mar 19; 19(2):186-7. PubMed ID: 18257907
    [No Abstract] [Full Text] [Related]

  • 72. What do we know about Kawasaki disease?
    Kucińska B, Wróblewska-Kałuzewska M.
    Med Sci Monit; 2000 Mar 19; 6(6):1227-31. PubMed ID: 11208484
    [Abstract] [Full Text] [Related]

  • 73. Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006.
    Son MB, Gauvreau K, Ma L, Baker AL, Sundel RP, Fulton DR, Newburger JW.
    Pediatrics; 2009 Jul 19; 124(1):1-8. PubMed ID: 19564276
    [Abstract] [Full Text] [Related]

  • 74. [Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].
    Kobayashi T, Inoue Y, Morikawa A.
    Nihon Rinsho; 2008 Feb 19; 66(2):332-7. PubMed ID: 18260333
    [Abstract] [Full Text] [Related]

  • 75. Kawasaki disease with predominant central nervous system involvement.
    Tabarki B, Mahdhaoui A, Selmi H, Yacoub M, Essoussi AS.
    Pediatr Neurol; 2001 Sep 19; 25(3):239-41. PubMed ID: 11587880
    [Abstract] [Full Text] [Related]

  • 76. Hemophagocytic lymphohistiocytosis prior to the diagnosis of Kawasaki disease.
    Ogawa M, Hoshina T.
    Indian Pediatr; 2015 Jan 19; 52(1):78. PubMed ID: 25638199
    [No Abstract] [Full Text] [Related]

  • 77. Treatment of Kawasaki disease using locally product intravenous immunoglobulin.
    Sangtawesin C, Kirawitaya T, Layangkool T, Nawasiri W, Vimolsarawong N.
    J Med Assoc Thai; 2003 Aug 19; 86 Suppl 3():S656-60. PubMed ID: 14700163
    [Abstract] [Full Text] [Related]

  • 78. Acute cardiac valvular involvement in Kawasaki Disease.
    Pellegrin MC, Taddio A, Lepore L.
    Clin Exp Rheumatol; 2011 Aug 19; 29(1 Suppl 64):S140. PubMed ID: 21586208
    [No Abstract] [Full Text] [Related]

  • 79. Two cases of Kawasaki disease presented with acute febrile jaundice.
    Kaman A, Aydın-Teke T, Gayretli-Aydın ZG, Öz FN, Metin-Akcan Ö, Eriş D, Tanır G.
    Turk J Pediatr; 2017 Aug 19; 59(1):84-86. PubMed ID: 29168370
    [Abstract] [Full Text] [Related]

  • 80. Treatment of Kawasaki disease.
    Taddio A, Rosé CD.
    N Engl J Med; 2007 Jun 28; 356(26):2747; author reply 2748. PubMed ID: 17600908
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.